Literature DB >> 1537526

A prospective study of risk for peptic ulcer disease in Seventh-Day Adventists.

J H Kurata1, A N Nogawa, D E Abbey, F Petersen.   

Abstract

Cross-sectional and prospective data were collected and analyzed to identify risk factors for the development of peptic ulcer disease in a population of 34,198 white, non-Hispanic Seventh-Day Adventists. On a life-style questionnaire administered in 1976, 3853 subjects reported ever having had a physician-diagnosed peptic ulcer for a lifetime prevalence of 13.5% for men and 11.0% for women. Odds ratios of greater than 2.0 (P less than 0.0001) were observed for use of "stronger pain relievers," current cigarette smoking, and history of rheumatism or other arthritis and coronary disease. For both sexes, lower but statistically significant odds ratios (P less than 0.05) were found for eating white bread, "snacking," ever having smoked cigarettes, low church involvement, poor dietary adherence, high blood pressure, rheumatoid arthritis, aspirin use, job frustration and dissatisfaction, having a "blue collar household," and having less education. During 3 years of follow-up, 154 incident cases of ulcer were identified. The average annual incidence was 1.7 per 1000. Multivariate adjusted relative risks were statistically significant for using stronger pain relievers (P less than 0.001), having rheumatic conditions (P = 0.006), and using aspirin (P = 0.013). These findings suggest that rheumatic disease and use of aspirin and stronger pain relievers are more important risk factors for development of peptic ulcer disease in certain populations than diet, life-style, or psychological or socioeconomic characteristics.

Entities:  

Mesh:

Year:  1992        PMID: 1537526     DOI: 10.1016/0016-5085(92)90176-y

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  11 in total

Review 1.  Giant duodenal ulcers.

Authors:  Eric Benjamin Newton; Mark R Versland; Thomas E Sepe
Journal:  World J Gastroenterol       Date:  2008-08-28       Impact factor: 5.742

2.  Double-blind comparison of lansoprazole 15 mg, lansoprazole 30 mg, and placebo in the maintenance of healed gastric ulcer.

Authors:  T O Kovacs; D Campbell; M Haber; P Rose; D E Jennings; J Richter
Journal:  Dig Dis Sci       Date:  1998-04       Impact factor: 3.199

3.  Morbidity and prescribing patterns for the middle-aged population of Scotland.

Authors:  F G Whitelaw; S L Nevin; R J Taylor; A H Watt
Journal:  Br J Gen Pract       Date:  1996-12       Impact factor: 5.386

Review 4.  Cyclo-oxygenase isoenzymes. How recent findings affect thinking about nonsteroidal anti-inflammatory drugs.

Authors:  J Y Jouzeau; B Terlain; A Abid; E Nédélec; P Netter
Journal:  Drugs       Date:  1997-04       Impact factor: 9.546

5.  Smoking and ulcer perforation.

Authors:  C Svanes; J A Søreide; A Skarstein; B T Fevang; P Bakke; S E Vollset; K Svanes; O Søoreide
Journal:  Gut       Date:  1997-08       Impact factor: 23.059

6.  Prevalence of peptic ulcer in dyspeptic patients and the influence of age, sex, and Helicobacter pylori infection.

Authors:  Hui-Chao Wu; Bi-Guang Tuo; Wei-Min Wu; Yuan Gao; Qing-Qing Xu; Kui Zhao
Journal:  Dig Dis Sci       Date:  2008-02-13       Impact factor: 3.199

7.  Prevalence and incidence of peptic ulcer disease in a Danish County--a prospective cohort study.

Authors:  S J Rosenstock; T Jørgensen
Journal:  Gut       Date:  1995-06       Impact factor: 23.059

8.  Associations of peptic ulcer and gastric cancer with other diseases in US veterans.

Authors:  A Sonnenberg; I H Wasserman
Journal:  Am J Public Health       Date:  1995-09       Impact factor: 9.308

9.  The PU-PROM: A patient-reported outcome measure for peptic ulcer disease.

Authors:  Na Liu; Jing Lv; Jinchun Liu; Yanbo Zhang
Journal:  Health Expect       Date:  2017-06-21       Impact factor: 3.377

10.  Combined Lycium babarum polysaccharides and C-phycocyanin increase gastric Bifidobacterium relative abundance and protect against gastric ulcer caused by aspirin in rats.

Authors:  Shu-Yu Hsieh; Yu Zhi Lian; I-Hsuan Lin; Yu-Chen Yang; Alexey A Tinkov; Anatoly V Skalny; Jane C-J Chao
Journal:  Nutr Metab (Lond)       Date:  2021-01-06       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.